Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

Recruiting now · Not applicable

Conditions studied: Heart Failure, Chronic Kidney Disease, End-stage Kidney Disease

In brief

The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.

Key facts

Study ID

NCT06877169

Run by

Cedars-Sinai Medical Center

People needed

20

Starts

2025-04-07

Expected to finish

2035-02-28

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (18 years or older) undergoing combined heart and kidney transplantation at Cedars-Sinai Medical Center.

You may not qualify if…

• Patients who undergo simultaneous heart/kidney transplantation in a single operative event due to medical necessity will be excluded.
• Patients with medical records flagged as "break-the-glass" or "research opt-out" within the center's electronic health record.

Where it is running

• Cedars-Sinai Medical Center — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.